In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2

In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2

The 2019 coronavirus infectious disease (COVID-19) is caused by infection with the new severe acute respiratory syndrome coronavirus (SARS-CoV-2). Currently, the treatment options for COVID-19 are limited. The purpose of the experiments presented here was to investigate the effectiveness of ketotife...

Full description

Bibliographic Details
Main Authors: Pantea Kiani, Andrew Scholey, Thomas A. Dahl, Lauren McMann, Jacqueline M. Iversen, Joris C. Verster
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Viruses
Subjects:
antiviral
drug repurposing
SARS-CoV-2
COVID-19
SJP-002C
indomethacin
Online Access:https://www.mdpi.com/1999-4915/13/4/558

Similar Items

Similar Items